Anna Janecka

3.0k total citations
111 papers, 2.5k citations indexed

About

Anna Janecka is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Oncology. According to data from OpenAlex, Anna Janecka has authored 111 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Molecular Biology, 62 papers in Cellular and Molecular Neuroscience and 20 papers in Oncology. Recurrent topics in Anna Janecka's work include Neuropeptides and Animal Physiology (60 papers), Receptor Mechanisms and Signaling (30 papers) and Biochemical and Structural Characterization (22 papers). Anna Janecka is often cited by papers focused on Neuropeptides and Animal Physiology (60 papers), Receptor Mechanisms and Signaling (30 papers) and Biochemical and Structural Characterization (22 papers). Anna Janecka collaborates with scholars based in Poland, France and Hungary. Anna Janecka's co-authors include Jakub Fichna, Tomasz Janecki, Katarzyna Gach, Jean Costentin, Jean‐Claude do Rego, Renata Perlikowska, Maria Zubrzycka, Martin Storr, Beata Biesaga and Karolina Szewczyk and has published in prestigious journals such as Analytical Biochemistry, Chemical Communications and Journal of Agricultural and Food Chemistry.

In The Last Decade

Anna Janecka

110 papers receiving 2.4k citations

Peers

Anna Janecka
Canan G. Nebigil France
Hiroshi Nomoto Japan
Richard D. Egleton United States
Simona Daniele Italy
Thaddeus F. Molski United States
Angela De Sarro Italy
Patrick Emond France
Maria F. Sassano United States
Young‐Sook Kang South Korea
Canan G. Nebigil France
Anna Janecka
Citations per year, relative to Anna Janecka Anna Janecka (= 1×) peers Canan G. Nebigil

Countries citing papers authored by Anna Janecka

Since Specialization
Citations

This map shows the geographic impact of Anna Janecka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Janecka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Janecka more than expected).

Fields of papers citing papers by Anna Janecka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Janecka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Janecka. The network helps show where Anna Janecka may publish in the future.

Co-authorship network of co-authors of Anna Janecka

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Janecka. A scholar is included among the top collaborators of Anna Janecka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Janecka. Anna Janecka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Długosz-Pokorska, Angelika, Tomasz Janecki, Anna Janecka, & Katarzyna Gach. (2024). New uracil analog as inhibitor/modulator of ABC transporters or/and NF-κB in taxol-resistant MCF-7/Tx cell line. Journal of Cancer Research and Clinical Oncology. 150(6). 328–328. 1 indexed citations
2.
3.
4.
Pietrzak, Anna, et al.. (2021). Synthesis and structure–activity relationship study of novel 3-diethoxyphosphorylfuroquinoline-4,9-diones with potent antitumor efficacy. European Journal of Medicinal Chemistry. 219. 113429–113429. 13 indexed citations
5.
Biesaga, Beata, et al.. (2019). The prevalence of HPV infection in rectal cancer – Report from South – Central Poland (Cracow region). Pathology - Research and Practice. 215(9). 152513–152513. 7 indexed citations
6.
7.
Gasińska, Anna, et al.. (2018). Biomarkers of epithelial-mesenchymal transition in localized, surgically treated clear-cell renal cell carcinoma. Folia Histochemica et Cytobiologica. 56(4). 195–206. 16 indexed citations
8.
9.
Słonina, Dorota, et al.. (2017). Low-Dose Hypersensitive Response for Residual pATM and γH2AX Foci in Normal Fibroblasts of Cancer Patients. International Journal of Radiation Oncology*Biology*Physics. 100(3). 756–766. 10 indexed citations
10.
Gach, Katarzyna & Anna Janecka. (2014). α-Methylene-γ-lactones as a Novel Class of Anti-leukemic Agents. Anti-Cancer Agents in Medicinal Chemistry. 14(5). 688–694. 25 indexed citations
11.
Perlikowska, Renata, et al.. (2013). Cyclization in Opioid Peptides. Current Drug Targets. 14(7). 798–816. 27 indexed citations
12.
Fichna, Jakub, Michael Dicay, Anna Janecka, et al.. (2011). Salvinorin A has antiinflammatory and antinociceptive effects in experimental models of colitis in mice mediated by KOR and CB1 receptors*. Inflammatory Bowel Diseases. 18(6). 1137–1145. 64 indexed citations
13.
Fichna, Jakub, Renata Perlikowska, Anna Wyrębska, et al.. (2011). Effect of 2′,6′-dimethyl-l-tyrosine (Dmt) on pharmacological activity of cyclic endomorphin-2 and morphiceptin analogs. Bioorganic & Medicinal Chemistry. 19(23). 6977–6981. 26 indexed citations
14.
Janecka, Anna, Renata Perlikowska, Katarzyna Gach, Anna Wyrębska, & Jakub Fichna. (2010). Development of Opioid Peptide Analogs for Pain Relief. Current Pharmaceutical Design. 16(9). 1126–1135. 40 indexed citations
15.
Perlikowska, Renata, Katarzyna Gach, Jakub Fichna, et al.. (2009). Biological activity of endomorphin and [Dmt1]endomorphin analogs with six-membered proline surrogates in position 2. Bioorganic & Medicinal Chemistry. 17(11). 3789–3794. 27 indexed citations
16.
Fichna, Jakub, Rudolf Schicho, Christopher N. Andrews, et al.. (2009). Salvinorin A inhibits colonic transit and neurogenic ion transport in mice by activating κ‐opioid and cannabinoid receptors. Neurogastroenterology & Motility. 21(12). 1326–1326. 63 indexed citations
17.
Janecki, Tomasz, et al.. (2005). 4-Methylideneisoxazolidin-5-ones—A new class of α-methylidene-γ-lactones with high cytostatic activity. Bioorganic & Medicinal Chemistry Letters. 16(5). 1430–1433. 25 indexed citations
18.
Fichna, Jakub, Anna Janecka, Piotr Kossoń, & Helmut R. Maëcke. (2004). Synthesis of HYNIC- and DOTA-Conjugates with mi-Opioid Receptor Ligands: Morphiceptin and Endomorphin-2. Polish Journal of Chemistry. 78(7). 951–959. 3 indexed citations
19.
Mirowski, Marek, Anna Janecka, Ewa Balcerczak, et al.. (2004). Uptake of radiolabeled morphiceptin and its analogs by experimental mammary adenocarcinoma: in vitro and in vivo studies. Nuclear Medicine and Biology. 31(4). 451–457. 3 indexed citations
20.
Janecka, Anna, Jakub Fichna, & Tomasz Janecki. (2004). Opioid Receptors and their Ligands. Current Topics in Medicinal Chemistry. 4(1). 1–17. 213 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Canan G. Nebigil Breakdown of academic impact, for papers by Hiroshi Nomoto Breakdown of academic impact, for papers by Richard D. Egleton Breakdown of academic impact, for papers by Simona Daniele Breakdown of academic impact, for papers by Thaddeus F. Molski Breakdown of academic impact, for papers by Angela De Sarro Breakdown of academic impact, for papers by Patrick Emond Breakdown of academic impact, for papers by Maria F. Sassano Breakdown of academic impact, for papers by Young‐Sook Kang
Rankless by CCL
2026